percentage of americans on glp 1 in 8 is now taking a GLP-1 medication. Yet for many patients, the conversation still begins and ends with weight loss. The future GLP-1 therapy lies in comprehensive protocols Chart: Most Americans Prefer Exercise
Description
A small human study examining the addition of phentermine to liraglutide found no meaningful additional weight loss compared to liraglutide alone
It also induces nitric oxidemediated vasodilation and thus may have implications for CV disease (68) and kidneys
The medication alone is not a complete solution for most people
Patient consent Written informed consent has been obtained from the patient for publication of the submitted article and accompanying images
